Do low levels of alanine aminotransferase, a baseline marker of sarcopenia and frailty, associate with worse clinical outcomes among hospitalized COVID-19 patients? A Retrospective Cohort Study.

Ehud Raz Gatt,Eyal Zilber, Max Perelman, Nitsan Landau, Maya Yakir,Noam Glick,Liat Negru,Gad Segal,Edward Itelman

Journal of frailty, sarcopenia and falls（2023）

引用 0|浏览2

暂无评分

摘要

In our analysis of COVID-19 patients, low ALT levels were independently associated with increased risk of mortality, both as standalone and when incorporated into a multivariate analysis.

查看译文

关键词

alanine aminotransferase,frailty,sarcopenia,worse clinical outcomes,clinical outcomes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要